Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anshen Dripping Pills is a Traditional Chinese Medicine (TCM) therapeutic developed by Tianjin Tasly Pharmaceutical for the treatment of insomnia, specifically targeting the "Heart and Liver Blood Deficiency" syndrome. The product utilizes the modernized "dripping pill" dosage form, which is designed to enhance the dissolution and bioavailability of its botanical components compared to traditional pill formats. The formulation is intended to nourish the blood and tranquilize the mind (An Shen), common therapeutic goals in TCM for addressing sleep disturbances. Clinical development has reached Phase 2 in China, focusing on evaluating the safety and efficacy of various dosages in patients with insomnia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Anshen Dripping Pills.